• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAQUET CARDIOPULMONARY GMBH HLM TUBING SET W/BIOLINE COATING; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAQUET CARDIOPULMONARY GMBH HLM TUBING SET W/BIOLINE COATING; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number BE-HLS 7050#HLS SET ADVANCED 7.0
Device Problem Coagulation in Device or Device Ingredient (1096)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/17/2020
Event Type  malfunction  
Event Description
There was a coagulation of the membrane on set be-hls 7050, lot 70130424.The hospital replaced the set and threw away the coagulated set.(b)(4).
 
Manufacturer Narrative
Device hirstory revord review result: affected product: 70104.6577 be-015703112#hls module advanced adult packaging lot: 70130424 (dms#2762657) production lot: 70129590 (dms#(b)(4)) the documentation for the packaging lot and production lot was reviewed on 2020-06-22.There were no references found, which are indicating a nonconformance of the product in question.A similar case was already investigate under complaint#310782: as stated in the investigation report of ot#310782 clots could be found inside the oxygenator.An increasing delta-p throughout the course of the extracorporeal circulation procedures, including ecmo, is an expected and known side effect.Whereas a rapid increase cannot be regarded as expected, the delta-p can also increase by none-coagulation relating factors, e.G.By ¿pseudofibrine deposits¿ which can be caused or promoted by drugs, such as propofol or by nutrition of the patient.According to the risk assessment (hls set advanced 5.0 / hls set advanced 7.0, dms # (b)(4), v23) following causes could lead to coagulation: -de-airing luer lock connection too loose -air remains in or enters the circuit -hemostasis -air or blood remains in luer lock access port -too low anticoagulation -too low at level, effect of heparin is too limited -protamine sulfate enters the hls set -administration of substitution of congealable substance such as plateles -(consumption) coagulopathy -thrombozytopenia thus the failure could be confirmed.The occurrence rate was calculated for the reported issue and it was determined that this is not a systemic issue.Therefore, no remedial action is required.The occurrence rate related to the reported issue is currently being monitored as part of maquet cardiopulmonary¿ s trending program and additional investigations or corrections will be implemented in case of adverse trending.
 
Event Description
Complaint id (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HLM TUBING SET W/BIOLINE COATING
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
MAQUET CARDIOPULMONARY GMBH
neue rottenburger strasse 37
hechingen
MDR Report Key9773935
MDR Text Key192167146
Report Number8010762-2020-00088
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
PMA/PMN Number
K112360
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Type of Report Initial,Followup
Report Date 06/22/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/02/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberBE-HLS 7050#HLS SET ADVANCED 7.0
Device Catalogue Number701047753
Was Device Available for Evaluation? No
Date Manufacturer Received06/22/2020
Is This a Reprocessed and Reused Single-Use Device? Yes
Patient Sequence Number1
-
-